FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and ...
Phycin has been selected to receive an award through the ReGen Valley Tech Hub Call for Commercialization Resources, marking ...
Sugar overload, chronic stress and modern lifestyles are rewiring your hormones. Together, they spark inflammation, disrupt ...
How shifting patient expectations and regulatory changes are reshaping Istanbul’s boutique, doctor-led clinics.
Hong Kong, Shanghai Tuesday, January 6, 2026, 13:00 Hrs [IST] ...
HONG KONG SAR - EQS Newswire - 30 December 2025 - Uni-Bio Science Group Limited ("Uni-Bio Science Group", "Uni-Bio" or "the Group") is pleased to announce the official signing of a tripartite ...
Fibrobiologics Inc. has filed an IND application with the FDA seeking to begin first-in-human trials of CYPS-317, an investigational allogeneic fibroblast spheroid-based therapy for the treatment of ...
HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma Hong Kong, Shanghai & Florham Park, NJ — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback